199 related articles for article (PubMed ID: 12383213)
1. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
Cameron RI; Maxwell P; Jenkins D; McCluggage WG
Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions.
McCluggage G; McBride H; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1997 Jan; 16(1):22-7. PubMed ID: 8986528
[TBL] [Abstract][Full Text] [Related]
4. A pre-tailored panel of antibodies in the study of cervical mesonephric remnants.
Pavlakis K; Messini I; Yiannou P; Chrissanthakis D; Papaspyrou I; Panoskaltsis T; Stathopoulos EN
Gynecol Oncol; 2010 Mar; 116(3):468-72. PubMed ID: 19913894
[TBL] [Abstract][Full Text] [Related]
5. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia.
Riethdorf L; Riethdorf S; Lee KR; Cviko A; Löning T; Crum CP
Hum Pathol; 2002 Sep; 33(9):899-904. PubMed ID: 12378514
[TBL] [Abstract][Full Text] [Related]
6. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
7. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
[TBL] [Abstract][Full Text] [Related]
8. p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia.
Walts AE; Bose S
Hum Pathol; 2009 Jul; 40(7):957-64. PubMed ID: 19269017
[TBL] [Abstract][Full Text] [Related]
9. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
[TBL] [Abstract][Full Text] [Related]
10. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
Aoun BA; Skala SL
Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium.
Stewart CJ; Little L
Pathology; 2010 Apr; 42(3):217-23. PubMed ID: 20350213
[TBL] [Abstract][Full Text] [Related]
12. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.
Qiao X; Bhuiya TA; Spitzer M
J Low Genit Tract Dis; 2005 Apr; 9(2):100-7. PubMed ID: 15870531
[TBL] [Abstract][Full Text] [Related]
13. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma.
McCluggage WG; McBride HA
Int J Gynecol Pathol; 2012 May; 31(3):206-10. PubMed ID: 22498936
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of p16 and Ki-67 expression in cervical glandular intraepithelial disease: A review.
Pereira Pinto P; Zanine RM
Ann Diagn Pathol; 2023 Feb; 62():152054. PubMed ID: 36396551
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions.
El-Ghobashy AA; Shaaban AM; Innes J; Prime W; Herrington CS
Eur J Cancer; 2007 Sep; 43(13):2011-8. PubMed ID: 17693084
[TBL] [Abstract][Full Text] [Related]
17. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
18. Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
Samarawardana P; Singh M; Shroyer KR
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):514-8. PubMed ID: 21602668
[TBL] [Abstract][Full Text] [Related]
19. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells.
Witkiewicz AK; Hecht JL; Cviko A; McKeon FD; Ince TA; Crum CP
Hum Pathol; 2005 Feb; 36(2):154-61. PubMed ID: 15754292
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
Chekmareva M; Ellenson LH; Pirog EC
Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
